天弘中证医药100A（001550）基金经理为贺雨轩。 截至发稿，贺雨轩累计任职时间4年225天，现任基金资产总规模112.26亿元，任职期间最佳基金回报 115.83%， 任职期间最差基金回报-61.43%。 声明：市场有风险，投资需谨慎。 本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本 文出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@staff.sina.com.cn。 责任编辑：小浪快报 数据显示，天弘基金旗下1只基金重仓奕瑞科技。天弘中证医药100A（001550）四季度持有股数13.4万 股，占基金净值比例为0.99%，位居第九大重仓股。根据测算，今日浮盈赚取约20.24万元。连续5天上 涨期间浮盈赚取164.02万元。 天弘中证医药100A（001550）成立日期2015年6月30日，最新规模6.92亿。今年以来收益2.73%，同类 排名2980/5580；近一年收益10.73%，同类排名3734/4290；成立以来亏损19.61%。 2月9日，奕瑞科技涨1.24%，截至发稿，报123.58元/股，成交3.77亿元，换手率1.54%，总 ...

Financial Performance - The company reported total revenue of 3.751 billion yuan for the first half of 2025, a decrease of 6.02% year-on-year [1] - The net profit attributable to shareholders was 163 million yuan, down 59.48% compared to the previous year [1] - The gross profit margin increased to 36.47%, up 3.58% year-on-year, while the net profit margin decreased to 5.64%, down 48.09% [1] - Total expenses (selling, administrative, and financial) amounted to 999.8 million yuan, accounting for 26.61% of total revenue, an increase of 32.03% year-on-year [1] Cash Flow and Debt Situation - The company had cash flow per share of 0.75 yuan, a decrease of 16.93% year-on-year [1] - The company’s cash and cash equivalents were reported at 1.875 billion yuan, a slight decrease of 1.26% [1] - The interest-bearing debt increased to 3.132 billion yuan, a rise of 49.82% year-on-year, leading to a debt-to-asset ratio of 43.74% [3] Market Position and Investment Insights - The company’s return on invested capital (ROIC) was 17.43%, indicating strong capital returns [3] - The company relies heavily on marketing-driven performance, which requires further analysis of the underlying factors [3] - The largest fund holding the company’s shares is Tianhong Zhongzheng Medicine 100A, with a recent net value increase of 0.8% and a one-year growth of 30.76% [4]